These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4045921)

  • 1. Substituent effects on the bioactivation of 2-(N-hydroxyacetamido)fluorenes by N-arylhydroxamic acid N,O-acyltransferase.
    Elfarra AA; Hanna PE
    J Med Chem; 1985 Oct; 28(10):1453-60. PubMed ID: 4045921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioactivation of N-hydroxy-2-acetylaminofluorenes by N,O-acyltransferase: substituent effects on covalent binding to DNA.
    Boteju LW; Hanna PE
    Carcinogenesis; 1993 Aug; 14(8):1651-7. PubMed ID: 8353850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenes.
    Marhevka VC; Ebner NA; Sehon RD; Hanna PE
    J Med Chem; 1985 Jan; 28(1):18-24. PubMed ID: 3965709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of N-(phenylalkyl)acetohydroxamic acids as potential substrates for N-arylhydroxamic acid N,O-acyltransferase.
    Elfarra AA; Yeh H; Hanna PE
    J Med Chem; 1982 Oct; 25(10):1189-92. PubMed ID: 7143355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
    Smith TJ; Hanna PE
    Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-arylhydroxamic acid N,O-acyltransferase. Positional requirements for the substrate hydroxyl group.
    Banks RB; Smith TJ; Hanna PE
    J Med Chem; 1983 Dec; 26(12):1780-4. PubMed ID: 6644748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylhydroxamic acid bioactivation via acyl group transfer. Structural requirements for transacylating and electrophile-generating activity of N-(2-fluorenyl)hydroxamic acids and related compounds.
    Yeh H; Hanna PE
    J Med Chem; 1982 Jul; 25(7):842-6. PubMed ID: 7108899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irreversible inhibition of rat hepatic transacetylase activity by N-arylhydroxamic acids.
    Wick MJ; Jantan IB; Hanna PE
    Biochem Pharmacol; 1988 Apr; 37(7):1225-31. PubMed ID: 3355596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of carcinogenic arylhydroxamic acids by human tissues.
    King CM; Olive CW; Cardona RA
    J Natl Cancer Inst; 1975 Aug; 55(2):285-7. PubMed ID: 1159819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suicide inactivation of hamster hepatic arylhydroxamic acid N,O-acyltransferase. A selective probe of N-acetyltransferase multiplicity.
    Hanna PE; Banks RB; Marhevka VC
    Mol Pharmacol; 1982 Jan; 21(1):159-65. PubMed ID: 7132954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative toxicity and mutagenicity of N-hydroxy-2-acetylaminofluorene and 7-acetyl-N-hydroxy-2-acetylaminofluorene in human lymphoblasts.
    Babson JR; Gavitt NE; Boteju LW; Hanna PE
    Mutat Res; 1992 Sep; 269(1):73-8. PubMed ID: 1381473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ; Kadlubar FF
    Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivation of N-arylhydroxamic acids by rat hepatic N-acetyltransferase. Detection of multiple enzyme forms by mechanism-based inactivation.
    Wick MJ; Hanna PE
    Biochem Pharmacol; 1990 Mar; 39(6):991-1003. PubMed ID: 2322300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylhydroxamic acid N,O-acyltransferase substrates. Acetyl transfer and electrophile generating activity of N-hydroxy-N-(4-alkyl-, 4-alkenyl-, and 4-cyclohexylphenyl)acetamides.
    Mangold BL; Hanna PE
    J Med Chem; 1982 Jun; 25(6):630-8. PubMed ID: 6765899
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
    Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
    Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of arylhydroxamic acids by N-O-acyltransferase of rat mammary gland.
    King CM; Traub NR; Lortz ZM; Thissen MR
    Cancer Res; 1979 Sep; 39(9):3369-72. PubMed ID: 476668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arylamine-nucleoside adduct formation: evidence for arylnitrene involvement in the reactions of an N-acetoxyarylamine.
    Boteju LW; Hanna PE
    Chem Res Toxicol; 1994; 7(5):684-9. PubMed ID: 7841348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylation, deacetylation and acyltransfer.
    King CM; Glowinski IB
    Environ Health Perspect; 1983 Mar; 49():43-50. PubMed ID: 6131820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of ovariectomy on the in vitro and in vivo activation of carcinogenic N-2-fluorenylhydroxamic acids by rat mammary gland and liver.
    Ritter CL; Bennett KK; Fullerton NF; Beland FA; Malejka-Giganti D
    Carcinogenesis; 1996 Nov; 17(11):2411-8. PubMed ID: 8968056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of cyclic nucleic acid adducts from some simple alpha, beta-unsaturated carbonyl compounds and cyclic nitrosamines.
    Chung FL; Hecht SS; Palladino G
    IARC Sci Publ; 1986; (70):207-25. PubMed ID: 3793173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.